Factors influencing hepatitis C cure in the era of direct-acting antivirals
Gastroenterol Hepatol. 2019 Sep:42 Suppl 1:1-7.
doi: 10.1016/S0210-5705(20)30181-3.
Epub 2020 Jun 16.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Aparato Digestivo, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, España.; Universitat de Barcelona, Barcelona, España. Electronic address: jcastellote@bellvitgehospital.cat.
- 2 Unidad de Sistema Digestivo, Hospital Universitario Ramón y Cajal, Madrid, España.
- 3 Unidad de Patologías Infecciosas, Hospital Universitario Álvaro Cunqueiro, Vigo, Pontevedra, España.
- 4 Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España; CIBEREHD, Instituto Carlos III, Madrid, España.
- 5 Unidad de Enfermedades Infecciosas y Microbiología, Hospital Nuestra Señora de Valme, Sevilla, España.
- 6 CIBEREHD, Instituto Carlos III, Madrid, España; Unidad de Hepatología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
- 7 Unidad de Hepatología, Hospital General Universitario Vall d'Hebron, Barcelona, España.
Abstract
Direct-acting antiviral agents are highly potent drugs with a strong genetic barrier. Consequently, the factors influencing hepatitis C cure have been reduced and have progressively lost importance. Host factors, such as the presence of cirrhosis, race, and treatment adherence, influence sustained viral response. Adherence, together with treatment errors and drug interactions, are also important, especially in older patients. Viral factors, such as viral load, genotype, and the presence of baseline resistances affect the response rate but their influence can be minimised by using pan-genotypic regimens. Treatment simplification and the high efficacy of new antiviral treatments will allow treatment universalisation and will hopefully enable elimination of the infection in the next few decades. Supplement information: This article is part of a supplement entitled "The value of simplicity in hepatitis C treatment", which is sponsored by Gilead. © 2019 Elsevier España, S.L.U. All rights reserved.
Keywords:
Adherence; Adherencia; Chronic hepatitis C; Cirrhosis; Cirrosis; Factores pronósticos; Genotipo; Genotype; Hepatitis crónica C; Prognostic factors; Respuesta viral; Sustained viral; response; sostenida.
Copyright © 2019 Elsevier España, S.L.U. Todos los derechos reservados.
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Drug Interactions
-
Genotype
-
Hepacivirus / genetics
-
Hepatitis C, Chronic / diagnosis
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Liver Cirrhosis / complications
-
Liver Cirrhosis / drug therapy
-
Medication Adherence
-
Substance-Related Disorders / drug therapy